Duloxetine HCL DR Capsules
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2D219R0052
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical plans to issue a solicitation for a national requirements contract for Duloxetine HCL DR capsules. The contract will be a firm-fixed price, requirements-type contract with a one-year base and four one-year options to provide Duloxetine HCL DR in various bottle counts and strengths for purchase by the Department of Defense, Department of Veterans Affairs, and Indian Health Service through DLA and VA prime vendor programs. Interested parties should contact the named contracting officer by September 2019 for any questions, as the solicitation is expected to be issued in September 2019.
There is no set-aside designation for this opportunity. The projected NAICS code is 325412, Pharmaceutical Preparation Manufacturing, and PSC code is 6505, Drugs (Pharmaceutical Preparations). The current contract holders were not named. Annual usage estimates will be provided in the solicitation schedule.
Notice text
4 versions
Update #4 · Latest ·
Correcting Duloxetine HCL DR to reflect capsules i/l/o tablets.
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Duloxetine HCL DR. Procurement details follow.Duloxetine HCL DR Capsules 20MG-60 count bottles; 30MG-30 count bottles; 30MG-90 count bottles; 60MG-30 count bottles and 60MG-1,000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) (phyllis.daraio@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre solicitation or solicitation changes through this website. The current projected solicitation date is October, 2019. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Update #3 ·
Correcting Duloxetine HCL DR to reflect capsules i/l/o tablets.
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Duloxetine HCL DR. Procurement details follow.
Duloxetine HCL DR Capsules 20MG-60 count bottles; 30MG-30 count bottles; 30MG-90 count bottles; 60MG-30 count bottles and 60MG-1,000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) (phyllis.daraio@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre solicitation or solicitation changes through this website. The current projected solicitation date is October, 2019. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Update #2 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Duloxetine HCL DR. Procurement details follow.
Duloxetine HCL DR Tablets 20MG-60 count bottles; 30MG-30 count bottles; 30MG-90 count bottles; 60MG-30 count bottles and 60MG-1,000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) (phyllis.daraio@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre solicitation or solicitation changes through this website. The current projected solicitation date is October, 2019. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Duloxetine HCL DR. Procurement details follow.
Duloxetine HCL DR Tablets 20MG-60 count bottles; 30MG-30 count bottles; 30MG-90 count bottles; 60MG-30 count bottles and 60MG-1,000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) (phyllis.daraio@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre solicitation or solicitation changes through this website. The current projected solicitation date is September, 2019. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Duloxetine HCL DR Capsules | Award Notice | |
| Duloxetine HCL DR Capsules | Solicitation | |
| Duloxetine HCL DR Capsules | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity